Tumor size, CA-19-9 levels, and TNM-T stage were significantly associated with LUCAT1 expression (p = 0.034 for tumor size, p < 0.001 for CA-19-9, p = 0.012 for TNM-T stage; Table 1), suggesting their involvement in CHOL progression. The gene discussed is LUCAT1; the disease is neoplasm.